Amicus Therapeutics US, LLC
UnclaimedPharmaceutical Preparation ManufacturingPhiladelphia, PA
Founded
2002
Primary NAICS
325412
CAGE code
867U3
Federal awards
$4.6M
Overview
Redefining Expectations in Rare Disease About Amicus Amicus is a wholly owned subsidiary of BioMarin Pharmaceutical Inc., a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Learn More About BioMarin We are guided by people living with rare diseases across the globe.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $1,221,010 | 24 |
| 2025 | Department of Veterans Affairs | $1,236,574 | 27 |
| 2024 | Department of Veterans Affairs | $978,666 | 35 |
| 2023 | Department of Veterans Affairs | $714,605 | 22 |
| 2022 | Department of Veterans Affairs | $452,218 | 24 |